DSP promotes responsible antibiotic manufacturing

DSM Sinochem Pharmaceuticals (DSP) will engage with its peers to identify solutions to the global health threat of antimicrobial resistance (AMR) as part of the Drug, Chemical and Associated Technologies Association (DCAT) Week 2016

DSP said it welcomes that an increasing number of pharmaceutical companies and their suppliers are starting to join forces and together address the role of irresponsible and polluting antibiotic manufacturing in accelerating AMR.

According to the AMR Review, the independent authority on AMR, concentrations of antibiotics found in manufacturing can be millions of times higher than safe limits, creating ‘hotspots’ for the emergence of resistant bacteria.

The topic of pharmaceutical pollution was also raised at the World Economic Forum in Davos followed by a “Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance” signed by leading pharmaceutical and generics companies.

DSP said using clean production technologies and dedicated wastewater treatment plants in combination with antimicrobial activity testing, form part of the basic requirements for clean, responsible and sustainable antibiotics production.

During this week, DCAT week 2016, DSP said invites its industry peers and relevant stakeholders for an active dialogue on this important matter.